PECO Q1 2026 Earnings Strong EPS Beat Driven by Robust Portfolio Performance TWAV Q3 2022 Earnings Steep EPS Miss Raises Concerns Over Profitability WFRD Q1 2026 Earnings Strong EPS Beat but Stock Declines OCSL Q1 2026 Earnings Slight EPS Beat Amid Stable Portfolio Performance Immunovant IMVT Q1 2026 Earnings NarrowerThanExpected Loss but EPS Miss Highlights RD Spending MGX Q1 2026 Earnings EPS Miss Reflects Increased RD Spending Amid Pipeline Progress